Christopher Gibson, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 40,000 shares at $4.47 ($179K) on 2026-01-20, disclosed to the SEC on 2026-01-22.
Seasonal sale ($179k) by Director — this insider has traded RXRX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RXRX | SELL | 2026-05-08 | $135K | — | Filing → |
| RXRX | SELL | 2026-04-24 | $144K | — | Filing → |
| RXRX | SELL | 2026-04-08 | $124K | — | Filing → |